FDA
approval
· 2011-01-20
FDA Approved: SULFASALAZINE — Supplemental Application (Sunrise Pharmaceutical, Inc.)
Summary
FDA approved a supplemental application submitted by Sunrise Pharmaceutical, Inc. under ANDA040349 to market a generic form of sulfasalazine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SULFASALAZINE (SULFASALAZINE)